<DOC>
	<DOC>NCT01012674</DOC>
	<brief_summary>The study will evaluate the efficacy and safety of Dotarem enhanced MRA in patients suffering from carotid or vertebral arterial disease.</brief_summary>
	<brief_title>Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)</brief_title>
	<detailed_description>Each subject will undergo a Time Of Flight (TOF) Magnetic Resonance Angiography (MRA) followed by a Dotarem enhanced MRA</detailed_description>
	<mesh_term>Cerebral Arterial Diseases</mesh_term>
	<criteria>Male or female, aged more than 18 years Strongly suspected of having carotid or vertebral arterial disease Scheduled (or to be scheduled) to undergo computed tomography angiography (CTA) examination Known grade IV or V chronic kidney disease (GFR&lt;30 mL/min/1.73m²) Contraindication to MRI Acute renal dysfunction within the 6 months preceding Dotarem®enhanced MRA examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>carotid or vertebral artery disease</keyword>
	<keyword>Contrast agent</keyword>
	<keyword>MRA</keyword>
</DOC>